# An in vivo and in vitro spatiotemporal profile of human midbrain development

**Authors:** Dimitri Budinger, Pau Puigdevall, George T. Hall, Charlotte Roth, Theodoros Xenakis, Elena Marrosu, Julie Jerber, Alessandro Di Domenico, Francesca Picco, Helena Kilpinen, Sergi Castellano, Manju A. Kurian, Serena Barral

PMC · DOI: 10.1038/s41467-025-67779-1 · Nature Communications · 2026-02-03

## TL;DR

This study compares fetal human midbrain development with lab-grown models to assess their similarity and usefulness in studying dopamine-related disorders.

## Contribution

The study provides a spatiotemporal profile of fetal midbrain development and validates midbrain organoids as relevant models for dopamine-related disorders.

## Key findings

- Fetal midbrain tissue by the second trimester shows structural complexity similar to adults.
- Midbrain organoids closely resemble late first trimester tissue in cellular composition.
- Spatial transcriptomics reveals that organoids capture the architecture and signaling of second trimester midbrain.

## Abstract

The dopaminergic system has key roles in human physiology and is implicated in a broad range of neurological and neuropsychiatric conditions that are increasingly investigated using induced pluripotent stem cell-derived midbrain models. To determine similarities of such models to human systems, here we undertake single-cell and spatial profiling of first and second trimester fetal midbrain and compare it to in vitro midbrain models. Histological examination reveals that, by the second trimester, fetal midbrain tissue exhibits structural complexity comparable to that of adults. At the molecular level, single-cell profiling uncovers differences in cellular composition across models, with brain organoids most closely resembling late first trimester tissue — an observation supported by meta-integration of existing midbrain datasets. By reconstructing developmental trajectories of neuronal and astrocytic lineages, we map gene expression dynamics associated with maturation. Importantly, integration of spatial transcriptomics provides critical context for aligning organoid models, revealing that their spatial organization and intercellular signaling resemble the architecture and microenvironment of the second trimester midbrain. Ultimately, we leverage our findings to study Dopamine Transporter Deficiency Syndrome progression in patient-derived midbrain organoids, validating their relevance. Understanding the extent of human tissue recapitulation in midbrain laboratory models is essential to justify their use as biological proxies.

This study provides a comprehensive profile of human fetal midbrain development and its comparison with lab-grown midbrain cultures. These findings demonstrate that midbrain organoids recapitulate fetal developmental stages while capturing essential spatial and molecular characteristics, relevant to dopamine-related disorders.

## Linked entities

- **Diseases:** Dopamine Transporter Deficiency Syndrome (MONDO:0013150)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** ALDH1L1 (aldehyde dehydrogenase 1 family member L1) [NCBI Gene 10840] {aka 10-FTHFDH, 10-fTHF, FDH, FTHFD}, NRN1 (neuritin 1) [NCBI Gene 51299] {aka NRN, dJ380B8.2}, AQP4 (aquaporin 4) [NCBI Gene 361] {aka MIWC, MLC4, WCH4, hAQP4}, ID4 (inhibitor of DNA binding 4) [NCBI Gene 3400] {aka IDB4, bHLHb27}, ZBTB20 (zinc finger and BTB domain containing 20) [NCBI Gene 26137] {aka DPZF, HOF, ODA-8S, PRIMS, ZNF288}, UQCRFS1 (ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1) [NCBI Gene 7386] {aka ISP, MC3DN10, RIP1, RIS1, RISP, UQCR5}, FGF8 (fibroblast growth factor 8) [NCBI Gene 2253] {aka AIGF, FGF-8, HBGF-8, HH6, KAL6}, COL9A3 (collagen type IX alpha 3 chain) [NCBI Gene 1299] {aka DJ885L7.4.1, EDM3, IDD, MED, STL6}, FEV (FEV transcription factor, ETS family member) [NCBI Gene 54738] {aka HSRNAFEV, PET-1}, LHX1 (LIM homeobox 1) [NCBI Gene 3975] {aka LIM-1, LIM1}, TUBA1A (tubulin alpha 1a) [NCBI Gene 7846] {aka B-ALPHA-1, LIS3, TUBA3}, TH (tyrosine hydroxylase) [NCBI Gene 7054] {aka DYT14, DYT5b, TYH}, WNT5A (Wnt family member 5A) [NCBI Gene 7474] {aka hWNT5A}, HES1 (hes family bHLH transcription factor 1) [NCBI Gene 3280] {aka HES-1, HHL, HRY, bHLHb39}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, LMO3 (LIM domain only 3) [NCBI Gene 55885] {aka RBTN3, RBTNL2, RHOM3, Rhom-3}, COX3 (cytochrome c oxidase subunit III) [NCBI Gene 4514] {aka COIII, MTCO3}, STMN2 (stathmin 2) [NCBI Gene 11075] {aka SCG10, SCGN10}, Camk2n1 (calcium/calmodulin-dependent protein kinase II inhibitor 1) [NCBI Gene 66259] {aka 1810006K23Rik}, RBFOX3 (RNA binding fox-1 homolog 3) [NCBI Gene 146713] {aka FOX-3, FOX3, HRNBP3, NEUN}, Th (tyrosine hydroxylase) [NCBI Gene 21823], DNASE1 (deoxyribonuclease 1) [NCBI Gene 403413], KCNJ6 (potassium inwardly rectifying channel subfamily J member 6) [NCBI Gene 3763] {aka BIR1, GIRK-2, GIRK2, KATP-2, KATP2, KCNJ7}, LMX1B (LIM homeobox transcription factor 1 beta) [NCBI Gene 4010] {aka FSGS10, LMX1.2, NPS1}, SOX10 (SRY-box transcription factor 10) [NCBI Gene 6663] {aka DOM, PCWH, SOX-10, WS2E, WS4, WS4C}, IL33 (interleukin 33) [NCBI Gene 90865] {aka C9orf26, DVS27, IL1F11, NF-HEV, NFEHEV}, COX1 (cytochrome c oxidase subunit I) [NCBI Gene 4512] {aka COI, MTCO1}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, ATP8 (ATP synthase F0 subunit 8) [NCBI Gene 4509] {aka ATPase8, MTATP8}, SLC25A21 (solute carrier family 25 member 21) [NCBI Gene 89874] {aka MTDPS18, ODC, ODC1}, OTX2 (orthodenticle homeobox 2) [NCBI Gene 5015] {aka CPHD6, MCOPS5}, SNCA (synuclein alpha) [NCBI Gene 6622] {aka NACP, PARK1, PARK4, PD1}, TPD52 (tumor protein D52) [NCBI Gene 7163] {aka D52, N8L, PC-1, PrLZ, hD52}, DDC (dopa decarboxylase) [NCBI Gene 1644] {aka AADC}, PTPRZ1 (protein tyrosine phosphatase receptor type Z1) [NCBI Gene 5803] {aka HPTPZ, HPTPzeta, PTP-ZETA, PTP18, PTPRZ, PTPZ}, PTN (pleiotrophin) [NCBI Gene 5764] {aka HARP, HB-GAM, HBBM, HBGF-8, HBGF8, HBNF}, SYT1 (synaptotagmin 1) [NCBI Gene 6857] {aka BAGOS, P65, SVP65, SYT}, GFAP (glial fibrillary acidic protein) [NCBI Gene 2670] {aka ALXDRD}, ADCY1 (adenylate cyclase 1) [NCBI Gene 107] {aka AC1, DFNB44}, MDK (midkine) [NCBI Gene 4192] {aka ARAP, MK, NEGF2}, SLC6A11 (solute carrier family 6 member 11) [NCBI Gene 6538] {aka GAT-3, GAT3, GAT4}, CYC1 (cytochrome c1) [NCBI Gene 1537] {aka MC3DN6, UQCR4}, PITX3 (paired like homeodomain 3) [NCBI Gene 5309] {aka ASGD1, ASMD, ASOD, CTPP4, CTRCT11}, PBX1 (PBX homeobox 1) [NCBI Gene 5087] {aka CAKUHED}, FOXA2 (forkhead box A2) [NCBI Gene 3170] {aka HNF-3-beta, HNF3B, TCF3B}, TUBB4B (tubulin beta 4B class IVb) [NCBI Gene 10383] {aka Beta2, LCAEOD, TUBB2, TUBB2C}, CALB1 (calbindin 1) [NCBI Gene 793] {aka CALB, D-28K}, Sparc (secreted acidic cysteine rich glycoprotein) [NCBI Gene 20692] {aka BM-40, ON}, SLC1A2 (solute carrier family 1 member 2) [NCBI Gene 6506] {aka DEE41, EAAT2, EIEE41, GLT-1, GLT1, HBGT}, SOX2 (SRY-box transcription factor 2) [NCBI Gene 6657] {aka ANOP3, MCOPS3}, NKX2-2 (NK2 homeobox 2) [NCBI Gene 4821] {aka NKX2.2, NKX2B}, ND2 (NADH dehydrogenase subunit 2) [NCBI Gene 4536] {aka MTND2}, TTYH1 (tweety family member 1) [NCBI Gene 57348], ND1 (NADH dehydrogenase subunit 1) [NCBI Gene 4535] {aka MTND1}, COL9A1 (collagen type IX alpha 1 chain) [NCBI Gene 1297] {aka DJ149L1.1.2, EDM6, MED, STL4}, VIM (vimentin) [NCBI Gene 7431], COX2 (cytochrome c oxidase subunit II) [NCBI Gene 4513] {aka COII, MTCO2}, ND5 (NADH dehydrogenase subunit 5) [NCBI Gene 17721], NSG2 (neuronal vesicle trafficking associated 2) [NCBI Gene 51617] {aka CALY3, HMP19}, NNAT (neuronatin) [NCBI Gene 4826] {aka Peg5}
- **Diseases:** neurological disease (MESH:D020271), attention deficit hyperactivity disorder (MESH:D001289), toxicity (MESH:D064420), dopaminergic neuronal loss (MESH:D009410), drug addiction (MESH:D019966), dopaminergic (MESH:D009422), neurodegeneration (MESH:D019636), neuropsychiatric conditions (MESH:D001523), mitochondrial dopaminergic-specific dysfunction (MESH:D028361), MLO (MESH:D020295), autism (MESH:D001321), inflammation (MESH:D007249), impaired (MESH:D060825), DTDS (MESH:C567730), PD (MESH:D010300), necrotic (MESH:D009336), parkinsonism (MESH:D010302), neurological disorders (MESH:D009461)
- **Chemicals:** AA (MESH:D001205), penicillin G (MESH:D010400), citrate (MESH:D019343), neuromelanin (MESH:C014121), CHIR99021 (MESH:C473711), GEM (-), purmorphamine (MESH:C470893), dopamine (MESH:D004298), melanin (MESH:D008543), methanol (MESH:D000432), DAPI (MESH:C007293), GlutaMax (MESH:C054122), Actinomycin D (MESH:D003609), calcium (MESH:D002118), heparin (MESH:D006493), N2 (MESH:D009584), Thiazovivin (MESH:C545214), Pen (MESH:C058388), PBS (MESH:D007854), LDN193189 (MESH:C554430), CO2 (MESH:D002245), acridine orange (MESH:D000165), paraffin (MESH:D010232), Haematoxylin (MESH:D006416), DTT (MESH:D004229), GABA (MESH:D005680), Eosin (MESH:D004801), SB431542 (MESH:C459179), F12 (MESH:C007782), Laemmli buffer (MESH:C088816), sucrose (MESH:D013395), H&amp;E (MESH:D006371), vitamin A (MESH:D014801), PFA (MESH:C003043), Tween (MESH:D011136), streptomycin (MESH:D013307), propidium iodide (MESH:D011419)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** initiation at 95, c.1103 T > A, c.1184 C > T, G2019S
- **Cell lines:** S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), MLO — Homo sapiens (Human), Human papillomavirus-related cervical squamous cell carcinoma, Cancer cell line (CVCL_WU75), hDA2 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_A628)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12877092/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12877092/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC12877092/full.md

---
Source: https://tomesphere.com/paper/PMC12877092